mTOR inhibitors have been shown to inhibit ALL growth and reverse glucocorticoid resistance and to work synergistically with other chemotherapeutic agents, such as dexamethasone, vincristine, and doxorubicin (Table 1) [119,120,121]. The gene discussed is MTOR; the disease is acute lymphoblastic leukemia.